Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy

NCT07628738 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07628738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07628738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy
Lead sponsor
Ruijin Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2026
Completion date
May 1, 2034
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma (non-hodgkin's lymphoma)